Abdominal Aortic Aneurysm clinical trials at UCSF
4 in progress, 2 open to eligible people
Endovascular Exclusion of Thoracoabdominal And/or Paravisceral Abdominal Aortic Aneurysm
open to eligible people ages 18 years and up
This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.
San Francisco, California and other locations
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
open to eligible people ages 20 years and up
The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.
San Francisco, California and other locations
Post-Approval Study of the TREO Abdominal Stent-Graft System
Sorry, in progress, not accepting new patients
The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.
Fresno, California and other locations
Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study
Sorry, not accepting new patients
The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.
San Francisco, California and other locations
Our lead scientists for Abdominal Aortic Aneurysm research studies include Warren J Gasper, MD Jade Hiramoto, MD.
Last updated: